Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07605078

Associations Between Household Mold Levels and Physical and Mental Health: A Mold and Mycotoxin Testing Research Registry

The primary purpose of this study is to evaluate cross-sectional associations between mold exposures identified with The Dust Test and self-reported physical health, emotional health, and medical diagnoses. In addition, associations between mold exposures and mycotoxin levels among users who have done mycotoxin lab testing will also be evaluated.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Mold Illness Mold or Dust Allergy

Sex eligibility

All sexes

Study type

Observational

Primary location

OvationLab

Richmond, Virginia, 23220, United States

Location status: Recruiting

Location contact

Study Administration

CONTACT

‪(240) 232-2103‬

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All Dust Test users who provide informed consent for deidentified analysis and peer-reviewed publication of their data will be eligible to participate in the research registry.

Exclusion criteria

  • Dust Test users who do not provide informed consent for deidentified analysis and peer-reviewed publication of their data.

Treatment and study plan

Mold-specific quantitative PCR (MSQPCR) testing

Other

The Dust Test is mold-specific quantitative PCR (MSQPCR) analysis that is being utilized to evaluate the associations between household mold organisms and a variety of human health outcomes.

Primary outcomes

  1. PROMIS - Global Health

    Time frame: Assessed at the time that the mold test is collected (cross-sectional)

    Ten questions assessing physical and mental health. Higher scores indicate superior physical and mental health.

Secondary outcomes

  1. Mold-related symptoms

    Time frame: Assessed at the time that the mold test is collected (cross-sectional)

    A set of 41 potentially mold-related symptoms. Higher scores indicated worse symptoms.

  2. Mycotoxin levels

    Time frame: Assessed at the time that the mold test is collected (cross-sectional)

    Urinary mycotoxin levels will be assessed. Higher levels indicated greater mycotoxin presence.

Study contacts

Contact information is provided by the study sponsor or research team.

Study Administrator

CONTACT

[email protected]

‪(240) 232-2103‬

Sponsors and collaborators

Lead sponsor

OvationLab

Network

Registry information

Important dates

Study start
2026
Primary completion
2029
Study completion
2029
First posted
May 22, 2026
Registry last updated
Jul 7, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.